Vasostrict
These highlights do not include all the information needed to use VASOSTRICT safely and effectively. See full prescribing information for VASOSTRICT . Vasostrict (vasopressin injection) for intravenous use Initial U.S. Approval: 2014
Approved
Approval ID
d162d386-105d-e916-e053-2995a90a350c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 3, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71872-7264
Application NumberNDA204485
Product Classification
M
Marketing Category
C73594
G
Generic Name
Vasopressin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 3, 2023
FDA Product Classification
INGREDIENTS (5)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM ACETATEInactive
Quantity: 1.36 mg in 1 mL
Code: 4550K0SC9B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
VASOPRESSIN, UNSPECIFIEDActive
Quantity: 20 [USP'U] in 1 mL
Code: Y87Y826H08
Classification: ACTIB